Context Therapeutics Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BIOIMPACT CAPITAL LLC | 11/14/2025 | 14.71 M | $14.25 M | 0.00% | 15.45% |
| AVIDITY PARTNERS MANAGEMENT LP | 11/14/2025 | 8.98 M | $8.70 M | 20.12% | 9.44% |
| NEXTECH INVEST, LTD. | 11/14/2025 | 7.42 M | $7.19 M | 0.00% | 7.79% |
| DEEP TRACK CAPITAL, LP | 11/14/2025 | 7.42 M | $7.19 M | 0.00% | 7.79% |
| BLUE OWL CAPITAL HOLDINGS LP | 11/12/2025 | 7.41 M | $7.18 M | 0.00% | 7.78% |
| GREAT POINT PARTNERS LLC | 11/14/2025 | 4.68 M | $4.54 M | 0.00% | 4.92% |
| FRANKLIN RESOURCES INC | 11/13/2025 | 4.00 M | $3.88 M | 0.00% | 4.21% |
| VANGUARD GROUP INC | 11/07/2025 | 3.50 M | $3.39 M | 4.00% | 3.67% |
| BLACKSTONE INC. | 11/14/2025 | 2.44 M | $2.36 M | 0.00% | 2.56% |
| ALYESKA INVESTMENT GROUP, L.P. | 11/17/2025 | 1.66 M | $1.61 M | 0.00% | 1.75% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 11/14/2025 | 1.66 M | $1.61 M | -14.13% | 1.75% |
| SIO CAPITAL MANAGEMENT, LLC | 11/13/2025 | 1.34 M | $1.30 M | 0.00% | 1.41% |
| BLACKROCK, INC. | 11/12/2025 | 848.97 K | $822.48 K | 0.00% | 0.89% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 608.58 K | $589.90 K | -4.58% | 0.64% |
| AFFINITY ASSET ADVISORS, LLC | 11/13/2025 | 402.65 K | $390.09 K | -22.27% | 0.42% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 11/14/2025 | 351.09 K | $340.14 K | 0.00% | 0.37% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2025 | 320.13 K | $310.14 K | -12.04% | 0.34% |
| STATE STREET CORP | 11/14/2025 | 152.61 K | $147.85 K | 0.00% | 0.16% |
| WALLEYE CAPITAL LLC | 11/14/2025 | 132.79 K | $128.64 K | 0.00% | 0.14% |
| HIGHTOWER ADVISORS, LLC | 11/07/2025 | 125.85 K | $121.93 K | 0.00% | 0.13% |
| PATHSTONE HOLDINGS, LLC | 11/13/2025 | 110.24 K | $106.80 K | 100.00% | 0.12% |
| MILL CREEK CAPITAL ADVISORS, LLC | 11/12/2025 | 104.63 K | $101.37 K | 0.00% | 0.11% |
| CITADEL ADVISORS LLC | 11/14/2025 | 103.36 K | $100.14 K | 100.00% | 0.11% |
| VELAN CAPITAL INVESTMENT MANAGEMENT LP | 11/14/2025 | 100.00 K | $96.88 K | 0.00% | 0.11% |
| CLEAR HARBOR ASSET MANAGEMENT, LLC | 11/14/2025 | 92.80 K | $89.91 K | 60.55% | 0.10% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2025 | 82.11 K | $79.55 K | -23.10% | 0.09% |
| NORTHERN TRUST CORP | 11/14/2025 | 66.38 K | $64.31 K | -41.55% | 0.07% |
| MARSHALL WACE, LLP | 11/13/2025 | 35.75 K | $34.68 K | 100.00% | 0.04% |
| ADVISOR GROUP HOLDINGS, INC. | 11/14/2025 | 25.50 K | $24.62 K | 142.86% | 0.03% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 21.97 K | $21.28 K | 100.00% | 0.02% |
| CERITY PARTNERS LLC | 10/22/2025 | 20.00 K | $19.38 K | 0.00% | 0.02% |
| CAXTON CORP | 11/14/2025 | 18.40 K | $17.83 K | 0.00% | 0.02% |
| XTX TOPCO LTD | 11/14/2025 | 10.60 K | $10.27 K | 100.00% | 0.01% |
| UBS GROUP AG | 11/13/2025 | 7.38 K | $7.15 K | 1,895.14% | 0.01% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 434 | $420 | -20.07% | 0.00% |
| BARCLAYS PLC | 11/12/2025 | 167 | $162 | 100.00% | 0.00% |
| SBI SECURITIES CO., LTD. | 11/05/2025 | 117 | $113 | 3.54% | 0.00% |
| MORGAN STANLEY | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| LUMINUS MANAGEMENT LLC | 10/03/2025 | 0 | $0 | -100.00% | 0.00% |
| GTS SECURITIES LLC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| WOODLINE PARTNERS LP | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| NEWBRIDGE FINANCIAL SERVICES GROUP, INC. | 11/13/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Context Therapeutics Inc. institutional Ownership - FAQ's
During the previous two years, 51 institutional investors and hedge funds held shares of Context Therapeutics Inc.. The most heavily invested institutionals were:
BioImpact Capital LLC: 14.71 M
Avidity Partners Management LP: 8.98 M
Nextech Invest, Ltd.: 7.42 M
Deep Track Capital, LP: 7.42 M
Blue Owl Capital Holdings LP: 7.41 M
GREAT POINT PARTNERS LLC: 4.68 M
72.45% of Context Therapeutics Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 77.47 M shares in the last 24 months. This purchase volume represents approximately $85.21 M in transactions.